Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

NCT03040726 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm
Nausea
Vomiting

Interventions

DRUG: Netupitant
DRUG: Palonosetron
DRUG: Palonosetron Hydrochloride
OTHER: Placebo
OTHER: Questionnaire Administration

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]